Chemical Structure (Cayston 01)
Not available.*
Cayston Kit
Product Images NDC 61958-0901
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Cayston (NDC 61958-0901). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Cayston 02)
Figure 1 (Cayston 03)
Figure 2a (Cayston 04)
Figure 2b (Cayston 05)
Figure 2c (Cayston 06)
Figure 2d (Cayston 07)
Figure 3 (Cayston 08)
This is a medicine product with a saline solution in an ampule format for injection.*
Figure 4 (Cayston 09)
This text is not available as it contains no relevant information to generate a useful description.*
Figure 5 (Cayston 10)
Figure 6 (Cayston 11)
Principal Display Panel (Cayston 28 Day Carton)
Cayston is an inhalation solution that contains 75mg of aztreonam per vial and is intended for oral inhalation only through the use of the Altera Nebulizer System. It is stored in a refrigerated environment at 2°C - 8°C and comes with 84 single-use vials of the solution, 88 diluent ampules of Sodium Chloride, and 4 additional ampules provided just in case of spillage. Each 73mg dose of Cayston is added to a reservoir of sodium chloride and inhaled using the Altera Nebulizer system. The package insert contains the dosage and administration guidelines. The product is manufactured by Gilead and distributed by GenaCare Pharmaceuticals.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
